Deepnoid Wins Awards at Global Medical Imaging AI Competition
"Proving Generative AI Capabilities in CT Imaging"
First Place in Two Categories at the Official MICCAI Registered Challenge
Deepnoid, a leading first-generation medical artificial intelligence (AI) developer in South Korea, announced on September 29 that it achieved first place in two categories and third place in one category at the global medical imaging AI competition, the 'VLM3D Challenge'.
The 'VLM3D Challenge' is the official registered challenge of the 'International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI) 2025', which was held in Daejeon on September 24. The competition utilizes 'CT-RATE', the world's largest open dataset of paired chest CT scans and radiology reports, to evaluate the innovativeness of 3D vision-language model technology. There are a total of four categories, each with its own task, and teams are ranked based on their performance in these tasks.
The 'M4CT' team, composed of Deepnoid researchers, participated in three categories using their proprietary 'M4CT' solution. Through their awards at the competition, Deepnoid demonstrated the technological excellence of their self-developed 3D vision-language model 'M4CT' on the global stage.
Among the three categories they entered, they won first place in both the self-supervised multi-abnormality localization and the multi-abnormality classification tasks. They also placed third in the automatic radiology report generation category.
Deepnoid is currently conducting multi-center clinical trials for 'M4CXR', a digital medical device that shares its technological foundation with 'M4CT'. M4CXR is a digital medical device that can interpret 41 types of lesions from chest X-ray images within seconds and automatically generate a draft radiology report. The company aims to obtain regulatory approval as early as the end of this year.
Park Jongkwon, leader of the 'M4CT' team, stated, "This achievement proves that Deepnoid's multimodal generative AI technology excels not only in 2D X-ray images but also in 3D imaging such as CT scans." He added, "We will continue to focus on research and development to commercialize 'M4CT' so that it can be effectively utilized in clinical settings in the future."
Hot Picks Today
Up to 600 Million Won for Semiconductors, 160 Million Won Bonus for Loss-Making Non-Memory… Samsung Electronics Labor and Management Reach Tentative Deal on Unprecedented Performance Compensation (Comprehensive)
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- [Exclusive] 450 Billion Won Korean Investment at Risk as Canadian PE Moves to Acquire US Ascend for $99.2 Million
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.